• EtzBetz@feddit.de
    link
    fedilink
    arrow-up
    2
    ·
    5 months ago

    The trial, which will take place at Kyoto University Hospital from September to August 2025, will treat 30 males aged 30-64 who are missing at least one molar.

    Is only testing on men still a thing in science? Since stuff can have different effects between genders, this could be bad for women.

    • deadbeef79000@lemmy.nz
      link
      fedilink
      arrow-up
      4
      ·
      5 months ago

      It’s not precluding a subsequent trial that includes women.

      Having said that, it is a little odd that it’s a men only trial.

      • EtzBetz@feddit.de
        link
        fedilink
        arrow-up
        3
        ·
        5 months ago

        Yeah of course. But as you’re saying, it’s just a little odd. History shows that focusing on one gender does eventually have bad consequences for the other gender.

      • saltesc@lemmy.world
        link
        fedilink
        arrow-up
        1
        ·
        5 months ago

        ADepending on the science being done, genders are preferred. In many cases it’s men due to less complex chemistry and internal anatomy. Men are more basic to start off with less risk of imbalance or damage if things go unexpectedly. Considering the nature of what’s being done, this isn’t at all odd for this trial. Sciences doesn’t recognise gender bias unless it’s studying gender bias.

    • Taleya@aussie.zone
      link
      fedilink
      arrow-up
      1
      ·
      5 months ago

      I can understand it from a very basic level of ‘simple first’ but if you’re doing human trial s you should be on a complex level already